Patient Reported Outcome Measures
"Patient Reported Outcome Measures" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Assessment of the quality and effectiveness of health care as measured and directly reported by the patient.
Descriptor ID |
D000071066
|
MeSH Number(s) |
E05.318.308.980.344.500 N03.349.380.210.750 N04.761.559.590.399.875 N05.425.210.500 N05.715.360.300.800.344.500 N05.715.360.575.575.399.875 N06.850.520.308.980.344.500
|
Concept/Terms |
Patient Reported Outcomes- Patient Reported Outcomes
- Outcome, Patient Reported
- Outcomes, Patient Reported
- Reported Outcome, Patient
- Reported Outcomes, Patient
- Patient Reported Outcome
|
Below are MeSH descriptors whose meaning is more general than "Patient Reported Outcome Measures".
Below are MeSH descriptors whose meaning is more specific than "Patient Reported Outcome Measures".
This graph shows the total number of publications written about "Patient Reported Outcome Measures" by people in this website by year, and whether "Patient Reported Outcome Measures" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 3 | 1 | 4 |
2017 | 4 | 4 | 8 |
2018 | 7 | 11 | 18 |
2019 | 13 | 11 | 24 |
2020 | 8 | 11 | 19 |
2021 | 3 | 10 | 13 |
2022 | 1 | 12 | 13 |
2023 | 1 | 8 | 9 |
2024 | 8 | 4 | 12 |
2025 | 4 | 3 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Patient Reported Outcome Measures" by people in Profiles.
-
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ Open Gastroenterol. 2025 Mar 31; 12(1).
-
Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76?K trial. Eur J Cancer. 2025 May 02; 220:115371.
-
Goal attainment in PMM2-CDG: A new approach measuring meaningful clinical outcomes. Mol Genet Metab. 2025 May; 145(1):109087.
-
Feasibility Study of Using Electronic Patient-Reported Outcomes to Screen Patients with Advanced Solid Cancers for Palliative Care Needs. J Palliat Med. 2025 May; 28(5):580-591.
-
Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia. Mov Disord. 2025 May; 40(5):917-927.
-
Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review. Inflamm Bowel Dis. 2025 Mar 03; 31(3):812-842.
-
Patient and clinical characteristics associated with pain during cesarean delivery: a prospective single-center patient-reported outcome study. Int J Obstet Anesth. 2025 Feb; 61:104324.
-
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703. J Clin Oncol. 2025 Mar 10; 43(8):912-918.
-
Patient-reported functional outcomes and treatment-related regret in Hispanic and Spanish-speaking men following prostate cancer treatment. Urol Oncol. 2025 Apr; 43(4):271.e19-271.e28.
-
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE?). Qual Life Res. 2025 Feb; 34(2):495-507.